These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8659015)

  • 1. A comparative study between etiological factors of calcium oxalate monohydrate and calcium oxalate dihydrate urolithiasis.
    Galán JA; Conte A; Llobera A; Costa-Bauzá A; Grases F
    Urol Int; 1996; 56(2):79-85. PubMed ID: 8659015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
    Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
    J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic calcium nephrolithiasis with pure calcium oxalate composition: clinical correlates of the calcium oxalate dihydrate/monohydrate (COD/COM) stone ratio.
    Guerra A; Ticinesi A; Allegri F; Pinelli S; Aloe R; Meschi T
    Urolithiasis; 2020 Jun; 48(3):271-279. PubMed ID: 31506762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between body mass index, lipid profiles, and types of urinary stones.
    Inci M; Demirtas A; Sarli B; Akinsal E; Baydilli N
    Ren Fail; 2012; 34(9):1140-3. PubMed ID: 22889148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of calcium oxalate monohydrate and dihydrate urolithiasis.
    Koide T; Itatani H; Yoshioka T; Ito H; Namiki M; Nakano E; Okuyama A; Takemoto M; Sonoda T
    J Urol; 1982 Jun; 127(6):1067-9. PubMed ID: 7087010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of passed calcium oxalate monohydrate and dihydrate stones].
    Hara Y
    Nihon Hinyokika Gakkai Zasshi; 1994 Sep; 85(9):1322-6. PubMed ID: 7967293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the specific incorporation of intracrystalline proteins into urinary calcium oxalate monohydrate and dihydrate crystals.
    Thurgood LA; Wang T; Chataway TK; Ryall RL
    J Proteome Res; 2010 Sep; 9(9):4745-57. PubMed ID: 20672853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone].
    Parent X; Boess G; Brignon P
    Prog Urol; 1999 Dec; 9(6):1051-6. PubMed ID: 10658250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evening urinary oxalate excretion in stone formers.
    Banks JG; Sullivan M; Hargreave TB
    Br J Urol; 1979 Oct; 51(5):349-51. PubMed ID: 533589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors in urinary calcium oxalate stone formation and their relation to urinary calcium oxalate supersaturation.
    Ogawa Y; Hatano T
    Int J Urol; 1996 Sep; 3(5):356-60. PubMed ID: 8886911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of calcium oxalate (mono- and dihydrate) in mixtures with magnesium ammonium phosphate or uric acid: the use of simultaneous thermal analysis in urinary calculi.
    Kaloustian J; El-Moselhy TF; Portugal H
    Clin Chim Acta; 2003 Aug; 334(1-2):117-29. PubMed ID: 12867282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal attachment to injured renal collecting duct cells: influence of urine proteins and pH.
    Wiessner JH; Hung LY; Mandel NS
    Kidney Int; 2003 Apr; 63(4):1313-20. PubMed ID: 12631348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential analysis of recurrent calcium calculi by infrared spectroscopy.
    Matsuzaki S; Matsushita K; Tanikawa K; Masuda A; Matsunaga J
    Int J Urol; 1995 Sep; 2(4):235-7. PubMed ID: 8564740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.